Two Different Regimens of Bemiparin as a Thromboprophylaxis in Morbidly Obese Surgical Patients

NARecruitingINTERVENTIONAL
Enrollment

2,400

Participants

Timeline

Start Date

January 7, 2023

Primary Completion Date

February 2, 2026

Study Completion Date

April 2, 2026

Conditions
Morbid Obesity
Interventions
DRUG

Bemiparin 3500

"Bemiparin sodium 3,500 IU anti Xa/0.2 ml solution for injection in the pre-filled syringe will be provided for each patient in one group; subcutaneously 6 hours after the surgery(orthopedic and non-orthopedic) and then daily for up to 10 days for moderate and high - risk group and for 30 days in very high risk-group patients according to Caprinin risk classification for venous thromboembolism.~Other Name: Hibor; Laboratories Rovi Pharmaceuticals"

DRUG

Bemiparin 5000 IU

"Bemiparin sodium 5000 IU anti Xa/0.2 ml solution for injection in the pre-filled syringe will be provided for each patient in one group; subcutaneously 6 hours after the surgery(orthopedic and non-orthopedic) and then daily for up to 10 days for moderate and high - risk group and for 30 days in very high risk-group patients according to Caprinin risk classification for venous thromboembolism.~Other Name: Hibor; Laboratories Rovi Pharmaceuticals"

Trial Locations (1)

44001

RECRUITING

Hawler Medical university, Erbil

All Listed Sponsors
lead

Hawler Medical University

OTHER